Here are five things to know:
1. KKR will make a $250 million investment into Henry Schein’s common stock on top of its existing holdings.
2. With the investment, KKR will have a 12% position in Henry Schein, making it the largest non-index fund shareholder in the company.
3. The investment firm will also have the option to buy additional shares through open market purchases up to a total equity stake of 14.9%.
4. Under the agreement between the two companies, Max Lin and William Daniel will join Henry Schein’s board of directors.
5. Henry Schein and KKR will collaborate to focus on driving strategic growth, operational efficiency and capital allocation.
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place November 12–14 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
